Investment in supply chain visibility reduces cost

By TSS

A risk-based approach to monitoring investigational medicinal products can help pharmaceutical companies improve supply chain efficiency, but to do this without compromising quality relies on fast access to comprehensive shipment data. Using a cloud temperature management solution and data loggers from TSS, GlaxoSmithKline has saved £4 million annually. World Pharmaceutical Frontiers hears from Rob Montague, director of supply chain logistics for investigational medicinal products at GSK; and Niclas Ohlsson, CEO of TSS.

Enter your details below to view the free white paper

By downloading this White Paper, you acknowledge that may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Business Trade Media International Limited may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.